MYC and cancer: Experimental overexpression of RNF43 in gastric tumor-derived cancer stem cells downregulates the β-catenin, TCF4 and c-Myc protein levels, sensitizes cells to chemotherapy and impairs their tumorigenicity in vivo [134].